Bevezetés: A gyomor polypoid elváltozásainak hazai előfordulási gyakorisága nem ismert. Cél: A szerzők célul tűzték ki a Semmelweis Egyetem, II. Belgyógyászati Klinika endoszkópos centrumában a gyomorpolip gyakoriságának és az azt befolyásoló kóroki tényezőknek a vizsgálatát. Módszerek: 16 hónap alatt végzett felső panendoszkópiák egységes szövettani és klinikai adatait értékelték. Eredmények: 4174 gasztroszkópia során 193 (4,62%) polipot észleltek. A betegek átlagéletkora a diagnóziskor 65,9±12,7 év volt. A polipok 33,67%-a hyperplasticus, 31,09%-a fundusmirigypolip, 2,07%-a malignus volt. A fundusmirigypolipos betegek körében gyakoribb volt a protonpumpagátló-használat (p = 0,007), míg a hyperplasticus polipos csoportban gyakrabban találtunk idült gastritist (p = 0,032). A Helicobacter pylori-fertőzöttség egyik szövettanú polip jelenlétével sem függött össze. Következtetés: Hazai betegek körében gyakoribb a gyomorpolip, mint az az irodalmi adatok alapján várható lenne. A fundusmirigypolipok gyakoribbak tartós protonpumpagátló-használó betegekben, a hyperplasticus polipok előfordulása pedig az idült gastritisek gyakoriságával mutat összefüggést. Orv. Hetil., 2013, 154, 770–774.
Schaff, Z., Illés, G.: Gastric tumors. In: Kopper, L., Schaff, Z. (eds.). Pathology 2. [A gyomor daganatai. In: Patológia 2.] Medicina Könyvkiadó, Budapest, 2004, 784–785. [Hungarian]
Illés G. , '', in Pathology 2. [Patológia 2.] , (2004 ) -.
Kumar, V., Abbas, A., Mitchell, R.: Robbins Basic Pathology. Hungarian translation. [A patológia alapjai.] Medicina Könyvkiadó, Budapest, 2009, 641–703. [Hungarian]
Mitchell R. , '', in Robbins Basic Pathology. [Hungarian translation. A patológia alapjai.] , (2009 ) -.
Guggenheim, D. E., Shah, M. A.: Gastric cancer epidemiology and risk factors. J. Surg. Oncol., 2013, 107, 230–236.
Shah M. A. , 'Gastric cancer epidemiology and risk factors ' (2013 ) 107 J. Surg. Oncol. : 230 -236 .
Hongo, M., Fujimoto, K.: Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in Japan. J. Gastroenterol., 2010, 45, 618–624.
Fujimoto K. , 'Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in Japan ' (2010 ) 45 J. Gastroenterol. : 618 -624 .
Odze, R. D., Goldblum, J. R. E.: Surgical pathology of the GI tract, liver, biliary tract, and pancreas. Saunders Elsevier, Philadelphia, 2009, 415–437.
Goldblum J. R. E. , '', in Surgical pathology of the GI tract, liver, biliary tract, and pancreas , (2009 ) -.
Raghunath, A. S., O’Morain, C., McLoughlin, R. C.: Review article: the long-term use of proton-pump inhibitors. Aliment. Pharmacol. Ther., 2005, 22 (Suppl. 1), 55–63.
McLoughlin R. C. , 'Review article: the long-term use of proton-pump inhibitors ' (2005 ) 22 Aliment. Pharmacol. Ther. : 55 -63 .
Leonard, J., Marshall, J. K., Moayyedi, P.: Systematic review of the risk of enteric infection in patients taking acid suppression. Am. J. Gastroenterol., 2007, 102, 2047–2056.
Moayyedi P. , 'Systematic review of the risk of enteric infection in patients taking acid suppression ' (2007 ) 102 Am. J. Gastroenterol. : 2047 -2056 .
Sanduleanu, S., Jonkers, D., de Bruïne, A., et al.: Changes in gastric mucosa and luminal environment during acid-suppressive therapy: a review in depth. Dig. Liver Dis., 2001, 33, 707–719.
Bruïne A. , 'Changes in gastric mucosa and luminal environment during acid-suppressive therapy: a review in depth ' (2001 ) 33 Dig. Liver Dis. : 707 -719 .
Hill, M. J.: The mechanism of carcinogenesis in the gastrointestinal tract. Z. Gastroenterol. Verh., 1989, 24, 141–146.
Hill M. J. , 'The mechanism of carcinogenesis in the gastrointestinal tract ' (1989 ) 24 Z. Gastroenterol. Verh. : 141 -146 .
Dirschmid, K., Platz-Baudin, C., Stolte, M.: Why is the hyperplastic polyp a marker for the precancerous condition of the gastric mucosa? Virchows Arch., 2006, 448, 80–84.
Stolte M. , 'Why is the hyperplastic polyp a marker for the precancerous condition of the gastric mucosa? ' (2006 ) 448 Virchows Arch. : 80 -84 .
Freeman, H. J.: Proton pump inhibitors and an emerging epidemic of gastric fundic gland polyposis. World J. Gastroenterol., 2008, 14, 1318–1320.
Freeman H. J. , 'Proton pump inhibitors and an emerging epidemic of gastric fundic gland polyposis ' (2008 ) 14 World J. Gastroenterol. : 1318 -1320 .
Jalving, M., Koornstra, J. J., Wesseling, J., et al.: Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy. Aliment. Pharmacol. Ther., 2006, 24, 1341–1348.
Wesseling J. , 'Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy ' (2006 ) 24 Aliment. Pharmacol. Ther. : 1341 -1348 .
Vieth, M., Stolte, M.: Fundic gland polyps are not induced by proton pump inhibitor therapy. Am. J. Clin. Pathol., 2001, 116, 716–720.
Stolte M. , 'Fundic gland polyps are not induced by proton pump inhibitor therapy ' (2001 ) 116 Am. J. Clin. Pathol. : 716 -720 .
Declich, P., Ambrosiani, L., Bellone, S., et al.: Fundic gland polyps under omeprazole treatment. Am. J. Clin. Pathol., 1999, 112, 576–577.
Bellone S. , 'Fundic gland polyps under omeprazole treatment ' (1999 ) 112 Am. J. Clin. Pathol. : 576 -577 .
Bertoni, G., Sassatelli, R., Nigrisoli, E., et al.: Dysplastic changes in gastric fundic gland polyps of patients with familial adenomatous polyposis. Ital. J. Gastroenterol. Hepatol., 1999, 31, 192–197.
Nigrisoli E. , 'Dysplastic changes in gastric fundic gland polyps of patients with familial adenomatous polyposis ' (1999 ) 31 Ital. J. Gastroenterol. Hepatol. : 192 -197 .
Shibata, C., Ogawa, H., Miura, K., et al.: Clinical characteristics of gastric cancer in patients with familial adenomatous polyposis. Tohoku J. Exp. Med., 2013, 229, 143–146.
Miura K. , 'Clinical characteristics of gastric cancer in patients with familial adenomatous polyposis ' (2013 ) 229 Tohoku J. Exp. Med. : 143 -146 .
Jalving, M., Koornstra, J. J, Götz, J. M., et al.: High-grade dysplasia in sporadic fundic gland polyps: a case report and review of the literature. Eur. J. Gastroenterol. Hepatol., 2003, 15, 1229–1233.
Götz J. M. , 'High-grade dysplasia in sporadic fundic gland polyps: a case report and review of the literature ' (2003 ) 15 Eur. J. Gastroenterol. Hepatol. : 1229 -1233 .
Ginsberg, G. G., Al-Kawas, F. H., Fleischer, D. E., et al.: Gastric polyps: relationship of size and histology to cancer risk. Am. J. Gastroenterol., 1996, 91, 714–717.
Fleischer D. E. , 'Gastric polyps: relationship of size and histology to cancer risk ' (1996 ) 91 Am. J. Gastroenterol. : 714 -717 .
Goddard, A. F., Badreldin, R., Pritchard, D. M., et al.: The management of gastric polyps. Gut, 2010, 59, 1270–1276.
Pritchard D. M. , 'The management of gastric polyps ' (2010 ) 59 Gut : 1270 -1276 .
Ohkusa, T., Takashimizu, I., Fujiki, K., et al.: Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori. A randomized, clinical trial. Ann. Intern. Med., 1998, 129, 712–715.
Fujiki K. , 'Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori. A randomized, clinical trial ' (1998 ) 129 Ann. Intern. Med. : 712 -715 .
Ljubicić, N., Banić, M., Kujundzić, M., et al.: The effect of eradicating Helicobacter pylori infection on the course of adenomatous and hyperplastic gastric polyps. Eur. J. Gastroenterol. Hepatol., 1999, 11, 727–730.
Kujundzić M. , 'The effect of eradicating Helicobacter pylori infection on the course of adenomatous and hyperplastic gastric polyps ' (1999 ) 11 Eur. J. Gastroenterol. Hepatol. : 727 -730 .